Form 4: AbbVie Director Rebecca B. Roberts Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Rebecca B. Roberts reports acquisition of restricted stock units and disposition of common stock in AbbVie Inc.
Summary
- On May 3, 2024, Rebecca B. Roberts, a director of AbbVie Inc., reported changes in her beneficial ownership of the company's securities.
- She acquired 1,322 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
- These restricted stock units will be paid in shares of AbbVie common stock upon separation from service, death, or a change in control.
- Roberts also disposed of 12,525 shares of common stock.
- Following these transactions, Roberts beneficially owns 12,525 shares of AbbVie common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to changes in beneficial ownership by a company insider, which is a common occurrence for publicly traded companies.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| July 10, 2023 | Date of Power of Attorney granted to Perry C. Siatis, Emily A. Weith, and T.O. Odutayo. |
| May 03, 2024 | Date of transaction involving acquisition of restricted stock units and disposition of common stock. |
| May 07, 2024 | Date of signature by Attorney-in-Fact for Rebecca B. Roberts. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.